ArticleTherapeutic advances in gastroenterology2025
Long-term risk of irritable bowel syndrome associated with triglyceride-glucose related indices: a large-scale prospective cohort study.
Article in Therapeutic advances in gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Insulin resistance (IR) may play a crucial role in irritable bowel syndrome (IBS) pathogenesis. However, it remains unclear whether triglyceride-glucose (TyG)-related indices, useful biomarkers for assessing IR, are associated with IBS development. Objectives: To investigated the link between baseline TyG-related indices and incident IBS. Design: A prospective, population-based cohort study. Methods: Participants free of IBS with available TyG-related indices (TyG-waist circumference (TyG-WC), TyG-waist-to-height ratio (TyG-WHtR), and TyG-body mass index (TyG-BMI)) at enrollment were included ( Results: During a median 14.6 years of follow-up (5,023,899 person-years), 7381 (2.1%) participants developed IBS. The mean (standard deviation) level of baseline TyG index was 8.7(0.6), with 8.0 (0.2), 8.5 (0.1), 8.9 (0.1), and 9.5 (0.3) in quartile 1-4. Compared with the lowest quartile, the highest quartile of all TyG-related indices was significantly associated with greater risk of incident IBS (TyG hazard ratio (HR) = 1.24, 95% confidence interval (CI): 1.16-1.33, <0.001; TyG-WC HR = 1.25, 95% CI: 1.16-1.34, <0.001; TyG-WHtR HR = 1.24, 95% CI: 1.16-1.33, <0.001; TyG-BMI HR = 1.15, 95% CI: 1.07-1.23, <0.001). Meanwhile, per standardized deviation increment of TyG-related indices were also associated with 6%-9% greater risk of IBS (TyG HR = 1.09, 95% CI: 1.07-1.12; TyG-WC HR = 1.09, 95% CI: 1.07-1.12; TyG-WHtR HR = 1.09, 95% CI: 1.06-1.11; TyG-BMI HR = 1.06, 95% CI: 1.03-1.08). Similar results were observed in various sensitivity analyses and subgroup analysis. Conclusion: Higher TyG-related indices are linked to higher risk of incident IBS, highlighting the importance of IR in IBS pathogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.